Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis

Objective: Rheumatoid arthritis (RA) is a systemic, immune-mediated inflammatory disease that ultimately leads to bone erosions and joint destruction. Methotrexate (MTX) slows bone damage but the mechanism by which it acts is still unknown. In this study, we aimed to assess the effect of MTX and low...

ver descrição completa

Detalhes bibliográficos
Autor principal: Caetano-Lopes, Joana (author)
Outros Autores: Rodrigues, Ana Maria (author), Campanilho-Marques, Raquel (author), Ponte, Cristina (author), Canhão, Helena (author), Ainola, Mari (author), Fonseca, João Eurico (author)
Formato: article
Idioma:eng
Publicado em: 2017
Assuntos:
Bone
DMARD
Monocytes
Osteoclast
Rheumatoid arthritis
Rheumatology
Immunology
Immunology and Allergy
Texto completo:https://doi.org/10.1136/rmdopen-2016-000365
País:Portugal
Oai:oai:run.unl.pt:10362/26651

Texto Completo

https://doi.org/10.1136/rmdopen-2016-000365

Registros relacionados